← Back to headlines
J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study
A late-stage study has shown that Johnson & Johnson's prostate cancer drug significantly reduces the risk of cancer spread and death in patients.
31 May, 13:35 — 31 May, 13:35
Sources
Showing 1 of 1 sources
